In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors
Credit: University of Colorado Cancer Center Two University of Colorado Cancer Center studies were presented this weekend at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics...





